Nothing Special   »   [go: up one dir, main page]

ATE247463T1 - TOPICALLY APPLIED STRUCTURAL TREATMENTS FOR CELLULITIS - Google Patents

TOPICALLY APPLIED STRUCTURAL TREATMENTS FOR CELLULITIS

Info

Publication number
ATE247463T1
ATE247463T1 AT95937481T AT95937481T ATE247463T1 AT E247463 T1 ATE247463 T1 AT E247463T1 AT 95937481 T AT95937481 T AT 95937481T AT 95937481 T AT95937481 T AT 95937481T AT E247463 T1 ATE247463 T1 AT E247463T1
Authority
AT
Austria
Prior art keywords
tewl
treatments
thigh
cellulite
elevate
Prior art date
Application number
AT95937481T
Other languages
German (de)
Inventor
Walter P Smith
Original Assignee
Mary Kay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mary Kay Inc filed Critical Mary Kay Inc
Priority claimed from PCT/US1995/013310 external-priority patent/WO1997014412A1/en
Application granted granted Critical
Publication of ATE247463T1 publication Critical patent/ATE247463T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

New topically applied treatments for cellulite are shown by comparative data to effect structural improvements in cellulite-afflicted thigh area tissues including skin-thickening, thigh-firming and thigh-reduction. The disclosed treatments disrupt the skin's water barrier and elevate trans-epidermal waterloss (TEWL) for extended periods of weeks or months and includes methods of mechanical or solvent action, for example, tape stripping, or acetone washes. Preferred treatments use creams with active ingredients such as lactic acid to elevate TEWL< a retinoid, preferably vitamin A palmitate to disrupt barrier rebuilding and prolong elevation of TEWL levels, and a cerebroside to inhibit lipid synthesis and intensify the TEWL elevation. Diuretics, for immediate esthetic improvements, anti-irritatts and anti-oxidants for irritation control are optional ingredients.
AT95937481T 1995-10-18 1995-10-18 TOPICALLY APPLIED STRUCTURAL TREATMENTS FOR CELLULITIS ATE247463T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/013310 WO1997014412A1 (en) 1994-08-26 1995-10-18 Topically applied, structural cellulite treatments

Publications (1)

Publication Number Publication Date
ATE247463T1 true ATE247463T1 (en) 2003-09-15

Family

ID=22249979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95937481T ATE247463T1 (en) 1995-10-18 1995-10-18 TOPICALLY APPLIED STRUCTURAL TREATMENTS FOR CELLULITIS

Country Status (4)

Country Link
CN (1) CN1200671A (en)
AT (1) ATE247463T1 (en)
AU (1) AU722070B2 (en)
DE (1) DE69531559D1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017027603A1 (en) 2015-08-10 2017-02-16 Mary Kay Inc. Topical compositions
CN115040542B (en) * 2022-08-15 2022-11-18 山东卓东生物科技有限公司 Application of mixture of exosome and retinal in preparing medicine for treating skin orange peel tissue

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition
US5391373A (en) * 1992-07-01 1995-02-21 Chanel, Inc. Skin cream composition

Also Published As

Publication number Publication date
AU722070B2 (en) 2000-07-20
AU3958395A (en) 1997-05-07
DE69531559D1 (en) 2003-09-25
CN1200671A (en) 1998-12-02

Similar Documents

Publication Publication Date Title
US5252604A (en) Compositions of retinoic acids and tocopherol for prevention of dermatitis
IL99291A (en) Cosmetic preparations
FR2782269B1 (en) COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING SALICYLIC ACID OR A SALICYLIC ACID DERIVATIVE AND USE THEREOF
US5587176A (en) Methods of using hesperetin for sebum control and treatment of acne
ES2129013A1 (en) Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis
ATE107160T1 (en) COSMETIC PREPARATIONS.
EP0852949A3 (en) Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation
KR101161682B1 (en) Use of an antioxidant in a dermatological and/or cosmetic composition
ATE161419T1 (en) COSMETIC COMPOSITION CONTAINING A LIPID SUBSTANCE AND A HYDROXY OR KETO FATTY ACID
MY101703A (en) Cosmetic
ATE183075T1 (en) AGENT CONTAINING RETINOID
BRPI0116293B1 (en) topical composition to prevent, ameliorate or treat skin hyperpigmentation
KR960010002A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
JP2005518399A (en) Method for improving the aesthetic appearance of the skin
US5804574A (en) Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US4992265A (en) Methods and compositions for increasing the diameter of the hair comprising retinol esters
US5811414A (en) Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
KR960010003A (en) L-carnitine salt and cosmetic composition and pharmaceutical composition for treating skin disease containing same
US5344651A (en) Cyproterone acetate thioacetate
DE69531559D1 (en) TOPICALLY APPLIED STRUCTURAL TREATMENTS FOR CELLULITIS
WO2001043705A2 (en) Compositions containing a retinoid and a stilbene for skin care
FI910308A0 (en) VITAMIN VITAMIN A PREPARATIONER FOER APPLICERING PAO HUDEN.
US5439901A (en) Cyproterone thiopivalate
AU707855B2 (en) Methods of using hesperetin for sebum control and treatment of acne
JPS60190713A (en) Melanine-suppressing agent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties